Helius Medical Technologies Inc (HSDT)

$3.61 -0.04 (-1.10%)
Market Cap 1.67M
Revenue (ttm) 520,000.00
Net Income (ttm) -11.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,257.69%
Debt to Equity Ratio 0.00
Volume 16,165
Avg Vol 16,926
Day's Range N/A - N/A
Shares Out 409,000.00
Stochastic %K 25%
Beta 1.11
Analysts Hold
Price Target $4.00

Latest News on HSDT

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

May 20, 2025, 7:00 AM EDT - 14 days ago

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

May 12, 2025, 7:00 AM EDT - 22 days ago

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies Announces Reverse Stock Split

Apr 30, 2025, 9:00 AM EDT - 4 weeks ago

Helius Medical Technologies Announces Reverse Stock Split

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary

Mar 13, 2025, 7:00 AM EDT - 2 months ago

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Mar 11, 2025, 7:00 AM EDT - 3 months ago

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Jan 22, 2025, 7:00 AM EST - 4 months ago

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

Jan 21, 2025, 8:00 PM EST - 4 months ago

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

Dec 23, 2024, 7:00 AM EST - 5 months ago

Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

Nov 18, 2024, 8:01 AM EST - 7 months ago

Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

Oct 14, 2024, 5:00 PM EDT - 8 months ago

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Aug 16, 2024, 5:00 PM EDT - 10 months ago

Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 9:33 PM EDT - 10 months ago

Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript

Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 4:05 PM EDT - 10 months ago

Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results

Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024

Aug 6, 2024, 4:36 PM EDT - 10 months ago

Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024

Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke

Jun 17, 2024, 7:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke

Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference

May 31, 2024, 12:30 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference

Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS

May 23, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS

Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

May 20, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

Helius Medical Technologies, Inc. (HSDT) Q1 2024 Earnings Call Transcript

May 13, 2024, 7:21 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q1 2024 Earnings Call Transcript

Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

May 13, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

May 10, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

May 6, 2024, 10:15 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

Apr 24, 2024, 9:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

Helius Medical stock rallies 40%: explore why

Apr 3, 2024, 7:55 AM EDT - 1 year ago

Helius Medical stock rallies 40%: explore why

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™

Apr 3, 2024, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™

Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 8:45 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

Mar 15, 2024, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

Mar 12, 2024, 8:59 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

Mar 7, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

Mar 4, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients

Feb 6, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients

Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists' Ability to Customize PoNS Therapy® to Improve Gait in People with MS

Feb 5, 2024, 7:05 AM EST - 1 year ago

Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists' Ability to Customize PoNS Therapy® to Improve Gait in People with MS

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

Jan 11, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

Helius Medical Technologies to Present at NobleCon19 Annual Conference

Nov 30, 2023, 7:47 AM EST - 1 year ago

Helius Medical Technologies to Present at NobleCon19 Annual Conference

Helius Medical Technologies, Inc (HSDT) Q3 2023 Earnings Call Transcript

Nov 12, 2023, 8:11 AM EST - 1 year ago

Helius Medical Technologies, Inc (HSDT) Q3 2023 Earnings Call Transcript

Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work

Nov 6, 2023, 7:05 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

Nov 2, 2023, 5:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices

Oct 12, 2023, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices

Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

Oct 2, 2023, 7:05 AM EDT - 1 year ago

Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece

Sep 28, 2023, 7:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece

Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference

Sep 21, 2023, 7:05 AM EDT - 1 year ago

Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference

University of Montreal's School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery

Sep 20, 2023, 7:05 AM EDT - 1 year ago

University of Montreal's School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery

Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference

Sep 13, 2023, 7:05 AM EDT - 1 year ago

Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference

Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing Criteria

Sep 5, 2023, 7:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing Criteria

Helius Medical Technologies, Inc. (HSDT) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 8:44 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q2 2023 Earnings Call Transcript

Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results

Aug 10, 2023, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results

Helius Medical Technologies, Inc. Announces Participation of Montefiore Medical Center in its PoNS® Therapeutic Experience Program

Aug 7, 2023, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Participation of Montefiore Medical Center in its PoNS® Therapeutic Experience Program

Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023

Aug 2, 2023, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023

Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina

Jul 27, 2023, 7:05 AM EDT - 2 years ago

Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina